FENNEC PHARMACEUTICALS INC

FENNEC PHARMACEUTICALS INC

Share · CA31447P1009 · FENC · A12A5F (XTSE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of FENNEC PHARMACEUTICALS INC
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
7
0
0
0
No Price
Closing Price XTSE 28.04.2026: 9,20 CAD
29.04.2026 05:27
Current Prices from FENNEC PHARMACEUTICALS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
FPIRSN09.DUSD
EUR
29.04.2026 05:27
5,75 EUR
-
XNAS: NASDAQ
NASDAQ
FENC
USD
28.04.2026 20:00
6,70 USD
-0,15 USD
-2,19 %
IEXG: IEX
IEX
FENC
USD
28.04.2026 19:59
6,69 USD
-0,16 USD
-2,34 %
XTSE: TSX
TSX
FRX.TO
CAD
28.04.2026 19:48
9,20 CAD
-0,20 CAD
-2,13 %
XDUS: Düsseldorf
Düsseldorf
FPIRSN09.DUSB
EUR
28.04.2026 14:00
5,55 EUR
-
Share Float & Liquidity
Free Float 47,81 %
Shares Float 13,66 M
Shares Outstanding 28,58 M
Company Profile for FENNEC PHARMACEUTICALS INC Share
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Company Data

Name FENNEC PHARMACEUTICALS INC
Company Fennec Pharmaceuticals Inc.
Symbol FENC
Website https://www.fennecpharma.com
Primary Exchange XTSE TSX
WKN A12A5F
ISIN CA31447P1009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jeffrey S. Hackman
Market Capitalization 263 Mio
Country United States of America
Currency CAD
Employees 0,0 T
Address 68 TW Alexander Drive, 27709 Research Triangle Park
IPO Date 2001-06-12

Stock Splits

Date Split
09.09.2014 1:3
05.09.2014 1:3
31.08.2011 1:18
02.08.2005 1:5

ID Changes

Date From To
30.01.2009 ADH FENC

Ticker Symbols

Name Symbol
Düsseldorf FPIRSN09.DUSB
Frankfurt RV41.F
NASDAQ FENC
Quotrix FPIRSN09.DUSD
TSX FRX.TO
More Shares
Investors who hold FENNEC PHARMACEUTICALS INC also have the following shares in their portfolio:
BUNDESIMMOBILIENGES.06/31
BUNDESIMMOBILIENGES.06/31 Bond
Quint:Ess.Str.Soc.Med.a.Techn. Inhaber-Anteile P o.N.
Quint:Ess.Str.Soc.Med.a.Techn. Inhaber-Anteile P o.N. Unbekannt